New York’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in New York 79
Jobs Directly Supported by the Industry in New York 110259
Annual Average Wage
Total Clinical Trials
Dollar Amount Invested in Clinical Trials
$917.2 Million
Clinical Trial Participants
Total Clinical Trial Economic Impact
$2.35 Billion

View Facilities By District

District Total Facilities in District View Facilities in District
NY01 5 BASF Corp (A) (2)

Codagenix Inc. (H)

Lixte Biotechnology Holdings, Inc (H)

Nikon Instruments (O)

NY07 1 Modern Meadow Inc. (A)
NY10 9 BeyondSpring Pharmaceuticals (H)

Celmatix, Inc. (H)

EpiVax Oncology, Inc. (H)

Flatiron Health (H)

Immunai (H)

J&J Innovation Center/ JLABS (O)

Kodikaz Therapeutic Solutions, Inc. (H)

New York Genome Center (O)

Tactical Therapeutics, Inc. (H)

NY12 43 Actinium Pharmaceuticals, Inc. (H)

Aisling Capital LLC (O)

Applied Therapeutics, Inc. (H)

Bioharmony Therapeutics Inc. (H)

BlueRock Therapeutics (H)

BrainStorm Cell Therapeutics (H)

Bristol Myers Squibb Company (H)

Brooklyn ImmunoTherapeutics, LLC (H)

Cooley LLP (O)

Cowen Inc. (O)

DBV Technologies (H)

Deerfield Institute (O)

Deerfield Management Company LP (O)

Elevation Oncology (H)

Équilibre Biopharmaceutical Corp. (H)

Forkhead BioTherapeutics Inc. (H)

iBio, Inc. (O)

ImClone Systems LLC (H)

IN8bio, Inc. (H)

Innovive Pharmaceuticals, Inc (H)

Intercept Pharmaceuticals, Inc. (H)

IVERIC bio (H)

Lodo Therapeutics (H)

MeiraGTx (H)

New York BIO (O)

New York Blood Center, Inc. (O)

OnCusp Therapeutics Inc (H)

Ovid Therapeutics Inc. (H)

Pfizer Inc. (H)

Pfizer Venture Investments (H)

Phosplatin Therapeutics (H)

Roche Pharmaceutical Research and Early Development (H)

Roche Translational & Clinical Research Center (H)

Rocket Pharma Ltd. (H)

Roivant Sciences, Inc. (H)

Royalty Pharma Management, LLC (O)

Sellas Life Sciences Group, Inc. (H)

SIGA Technologies, Inc (H)

The Rockefeller University (O)

TONIX Pharmaceuticals, Inc (H)

Torreya (O)

Venable|Fitzpatrick (O)

Y-mAbs Therapeutics, Inc (H)

NY13 2 Modular Genetics (H)

Stellate Therapeutics (H)

NY16 7 Acorda Therapeutics, Inc. (H)

BASF Corp (A)

Bayer Corporation (H)

Caladrius Biosciences, Inc (H)

Oligomerix, Inc. (H)

Regeneron Pharmaceuticals, Inc. (H)

Sapience Therapeutics Inc. (H)

NY17 1 BASF Corp (A)
NY19 1 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (H)
NY20 2 Cargill, Incorporated (A)


NY21 2 ConSynance Therapeutics, Inc. (H)

Regeneron Pharmaceuticals, Inc. (H)

NY22 2 Bristol-Myers Squibb Company (H)

Cargill, Incorporated (A)

NY24 1 Cargill, Incorporated (A)
NY25 1 University of Rochester (O)
NY26 2 BASF Corp (A)

MimiVax, LLC (H)